Bruce Power’s vision to use the power of nuclear energy to aid in the fight against cancer advanced recently with the formation of the Ontario Isotope Innovation Hub. This includes the unveiling of the Kinectrics Center for Medical Isotopes and Nuclear Chemistry. Together, these announcements strengthen Ontario’s position as an international player in the production of life-saving medical isotopes.

The Kinectrics’ Centre for Medical Isotopes & Nuclear Chemistry will transform innovative ideas and concepts into new made-in-Ontario medical isotope products and services.  The centre aims to extend its capabilities across the medical isotope supply chain from stable isotope enrichment to the international supply of the next generation of therapeutic and imaging isotopes for cancer treatment and diagnoses.

In addition, Isogen (a joint venture between Kinectrics and Framatome) and Bruce Power announced the launch of a Global Expressions of Interest Process (EOI) for radiopharmaceutical organizations interested in locating in Ontario for isotope production. This process will run until mid-2023 and will help further cement and augment Ontario and Canada’s role in the supply of isotopes .

To read more please visit:

Bruce Power establishes a new Ontario-based medical isotope hub to assist in global cancer fight

Source: BrucePower